AR032074A1 - Microparticulas lipidicas por micronizacion criogenica - Google Patents

Microparticulas lipidicas por micronizacion criogenica

Info

Publication number
AR032074A1
AR032074A1 ARP010106067A ARP010106067A AR032074A1 AR 032074 A1 AR032074 A1 AR 032074A1 AR P010106067 A ARP010106067 A AR P010106067A AR P010106067 A ARP010106067 A AR P010106067A AR 032074 A1 AR032074 A1 AR 032074A1
Authority
AR
Argentina
Prior art keywords
micronization
criogenic
lipid microparticles
microparticles
lipid
Prior art date
Application number
ARP010106067A
Other languages
English (en)
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of AR032074A1 publication Critical patent/AR032074A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente se refiere a micropartículas lipídicas que constan de lípidos enriquecidos con componentes anfifílicos, que promueven la incorporacion de péptidos y/o proteínas, proceso para la obtencion de los mismos y uso de los mismos. Asimismo, se revela un proceso de micronizacion criogénica para la elaboracion de los mismos.
ARP010106067A 2000-12-27 2001-12-27 Microparticulas lipidicas por micronizacion criogenica AR032074A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00128556 2000-12-27
EP01125741 2001-10-26

Publications (1)

Publication Number Publication Date
AR032074A1 true AR032074A1 (es) 2003-10-22

Family

ID=26071690

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010106067A AR032074A1 (es) 2000-12-27 2001-12-27 Microparticulas lipidicas por micronizacion criogenica

Country Status (12)

Country Link
US (1) US7704525B2 (es)
JP (1) JP4748923B2 (es)
AR (1) AR032074A1 (es)
AT (1) ATE373471T1 (es)
AU (1) AU2002219198B2 (es)
CA (1) CA2431890C (es)
DE (1) DE60130580T2 (es)
DK (1) DK1345593T3 (es)
ES (1) ES2290095T3 (es)
IL (2) IL156532A0 (es)
PT (1) PT1345593E (es)
WO (1) WO2002051386A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
CN1558755A (zh) 2001-09-26 2004-12-29 ���ع��ʹ�˾ 通过分散和除去溶剂或液相制备亚微米大小的纳米颗粒
EP1748788A1 (en) 2004-05-17 2007-02-07 Ares Trading S.A. Hydrogel interferon formulations
CN1993139B (zh) 2004-06-01 2011-02-16 阿雷斯贸易股份有限公司 稳定的干扰素液体制剂
PT2234645E (pt) 2007-12-20 2012-05-21 Merck Serono Sa Formulações de peg-interferão-beta
WO2012059936A1 (en) 2010-11-03 2012-05-10 Padma Venkitachalam Devarajan Pharmaceutical compositions for colloidal drug delivery
US9505771B2 (en) * 2011-05-18 2016-11-29 Laboratories Lesvi S.L. Stable micronised monoclin form of asenapine maleate and its synthesis
DE102013224627A1 (de) 2013-11-29 2015-06-03 Andreas Lauterbach Pharmazeutische Formulierung mit Lipidmikropartikeln und Herstellungsverfahren

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3024416C2 (de) * 1980-06-28 1982-04-15 Gödecke AG, 1000 Berlin Verfahren zur Herstellung von Arzneimitteln mit retardierter Wirkstoff-Freisetzung
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
US4837381A (en) * 1986-08-11 1989-06-06 American Cyanamid Company Compositions for parenteral administration and their use
ES2039219T3 (es) * 1986-08-11 1993-09-16 American Cyanamid Company Composiciones para administracion parenteral y su uso.
US4935491A (en) * 1987-08-24 1990-06-19 Board Of Regents, The University Of Texas System Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
IE904098A1 (en) * 1989-11-13 1991-05-22 Nova Pharm Corp Lipospheres for controlled delivery of substances
AU658608B2 (en) * 1991-03-25 1995-04-27 Astellas Pharma Europe B.V. Topical preparation containing a suspension of solid lipid particles
US5707648A (en) * 1993-11-17 1998-01-13 Lds Technologies, Inc. Transparent liquid for encapsulated drug delivery
US5430021A (en) * 1994-03-18 1995-07-04 Pharmavene, Inc. Hydrophobic drug delivery systems
DE19819273A1 (de) * 1998-04-30 1999-11-11 Pharmatec International S Giul Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung

Also Published As

Publication number Publication date
US7704525B2 (en) 2010-04-27
ATE373471T1 (de) 2007-10-15
IL156532A (en) 2011-04-28
JP4748923B2 (ja) 2011-08-17
IL156532A0 (en) 2004-01-04
PT1345593E (pt) 2007-10-10
WO2002051386A2 (en) 2002-07-04
US20040091522A1 (en) 2004-05-13
CA2431890C (en) 2011-05-10
JP2004529864A (ja) 2004-09-30
DK1345593T3 (da) 2007-12-10
DE60130580D1 (de) 2007-10-31
DE60130580T2 (de) 2008-06-12
AU2002219198B2 (en) 2006-06-29
WO2002051386A3 (en) 2002-10-10
ES2290095T3 (es) 2008-02-16
CA2431890A1 (en) 2002-07-04

Similar Documents

Publication Publication Date Title
AR025750A1 (es) Vacunas
BR0000126A (pt) Adjuvantes para uso em vacinas
ES2161085T3 (es) Formulaciones que contienen oxaliplatino.
AR032074A1 (es) Microparticulas lipidicas por micronizacion criogenica
DE69508598D1 (de) Mit polyethylenglycol modifizierte ceramidlipide und liposomen
BR122013013162A2 (pt) Uso de rivastigmina para preparar um sistema terapêutico transdérmico (tts)
AR001686A1 (es) Una composición vacuna un proceso para prepararla y su uso para la fabricación de una vacuna
ATE197898T1 (de) Lipidmischung vesikeln
ECSP045470A (es) Productos biologicos
ES2182850T3 (es) Procedimientos y composiciones para la microencapsulacion de adyuvantes.
ES2109254T3 (es) Proteinas antigenas y vacunas que las contienen para la prevencion de cocidiosis.
GT200200133A (es) Formulaciones de latex libres de aceleradores, metodos para hacer dichas formulaciones y articulos hechos de los mismos
ES2051678T1 (es) Derivados de 5-oxo-l-prolina y uso farmaceutico de los mismos.
BR0110922A (pt) Deslocamento de meios de fixação para fabricação de fraldas pré-fixadas e refixáveis
AR050641A1 (es) Proceso para la concentracion de anticuerpos y productos terapeuticos de los mismos
ES2530769T3 (es) Métodos para la activación de células T in vivo por células dendríticas pulsadas con antígeno
AR020999A1 (es) Composiciones y proceso para la elaboracion de isotretinoina
ES2138588T3 (es) Composiciones de vacunas que contienen liposomas.
UY26370A1 (es) "imidazo-5-il-aminas bicíclicas, medicamentos que las contienen, su uso para la preparación de medicamentos y procedimiento para su preparación".
GT200200028A (es) Compuestos de ppar
ATE544470T1 (de) Immuntherapeutische methoden und zusammensetzungen
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
ES2171985T3 (es) Procedimiento para la preparacion de agentes de contraste destinados a la tomografia por resonancia magnetica.
DK0542923T3 (da) Liposomer, som giver thumusafhængig hjælp til svage vaccineantigener
PA8469101A1 (es) Ligandos azabiciclicos de receptores 5ht1

Legal Events

Date Code Title Description
FG Grant, registration